Dr Alma Kimberly Leaird, MD | |
520 S Eagle Rd Ste 3211, Meridian, ID 83642-6356 | |
(208) 706-5930 | |
Not Available |
Full Name | Dr Alma Kimberly Leaird |
---|---|
Gender | Female |
Speciality | Rheumatology |
Experience | 36 Years |
Location | 520 S Eagle Rd Ste 3211, Meridian, Idaho |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154408219 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 35492 (Tennessee) | Secondary |
207RR0500X | Internal Medicine - Rheumatology | MC-1637 (Idaho) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Luke's Regional Medical Center | Boise, ID | Hospital |
St Luke's Nampa Medical Center | Nampa, ID | Hospital |
Summa Health System | Akron, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Summa Physicians Inc | 2961303532 | 640 |
News Archive
A new study shows that caregivers of dementia patients who must make the difficult decision to place their relatives into institutionalized care get no relief from depression and anxiety, and in fact suffer additional emotional trauma following their decision.
The anticipated onset of a second wave of the H1N1 influenza pandemic could present a host of thorny medical ethics issues best considered well in advance, according to the University of Toronto Joint Centre for Bioethics, which today released nine papers for public discussion.
Immunotherapies for cancer -; treatments that prime the immune system to attack tumors -; are valuable weapons in the anti-cancer arsenal. But some cancers are more difficult to target with this strategy than others.
Emisphere Technologies, Inc. today announced that Novartis Pharma AG and its license partner Nordic Bioscience a/s have reported the following in connection with their Phase III Study 2302 in osteoarthritis assessing the safety and efficacy of oral calcitonin in the treatment of osteoarthritis of the knee.
› Verified 3 days ago
Entity Name | Summa Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
A new study shows that caregivers of dementia patients who must make the difficult decision to place their relatives into institutionalized care get no relief from depression and anxiety, and in fact suffer additional emotional trauma following their decision.
The anticipated onset of a second wave of the H1N1 influenza pandemic could present a host of thorny medical ethics issues best considered well in advance, according to the University of Toronto Joint Centre for Bioethics, which today released nine papers for public discussion.
Immunotherapies for cancer -; treatments that prime the immune system to attack tumors -; are valuable weapons in the anti-cancer arsenal. But some cancers are more difficult to target with this strategy than others.
Emisphere Technologies, Inc. today announced that Novartis Pharma AG and its license partner Nordic Bioscience a/s have reported the following in connection with their Phase III Study 2302 in osteoarthritis assessing the safety and efficacy of oral calcitonin in the treatment of osteoarthritis of the knee.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Alma Kimberly Leaird, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: () - | Dr Alma Kimberly Leaird, MD 520 S Eagle Rd Ste 3211, Meridian, ID 83642-6356 Ph: (208) 706-5930 |
News Archive
A new study shows that caregivers of dementia patients who must make the difficult decision to place their relatives into institutionalized care get no relief from depression and anxiety, and in fact suffer additional emotional trauma following their decision.
The anticipated onset of a second wave of the H1N1 influenza pandemic could present a host of thorny medical ethics issues best considered well in advance, according to the University of Toronto Joint Centre for Bioethics, which today released nine papers for public discussion.
Immunotherapies for cancer -; treatments that prime the immune system to attack tumors -; are valuable weapons in the anti-cancer arsenal. But some cancers are more difficult to target with this strategy than others.
Emisphere Technologies, Inc. today announced that Novartis Pharma AG and its license partner Nordic Bioscience a/s have reported the following in connection with their Phase III Study 2302 in osteoarthritis assessing the safety and efficacy of oral calcitonin in the treatment of osteoarthritis of the knee.
› Verified 3 days ago
Mr. Eric Ld Scholten, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2347 E Gala St, Meridian, ID 83642 Phone: 208-323-3767 Fax: 208-323-3768 | |
Lynn Ge-zerbe, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1759 S Millenium Way, Meridian, ID 83642 Phone: 208-387-6546 Fax: 888-334-8747 | |
Dr. Aaron Dunham, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3025 W Cherry Lane, Ste 204, Meridian, ID 83642 Phone: 208-302-3300 Fax: 208-302-3355 | |
Oleg Sergeevich Kouskov, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2347 E Gala St, Meridian, ID 83642 Phone: 208-323-3767 | |
John T Witte, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2235 E Gala St, Meridian, ID 83642 Phone: 208-887-3724 Fax: 208-887-3724 | |
John B Dever, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 875 S Vanguard Way Ste 310, Meridian, ID 83642 Phone: 208-463-3000 | |
Dr. Wendi M Norris, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2347 E Gala St, Meridian, ID 83642 Phone: 208-323-0031 Fax: 208-323-0064 |